Marker TherapeuticsMRKR
13F holders, Q2 2024 (June 30)27holders
2new positions
2sold out
1famous investor
$5.43avg. 13F price*
At the end of Q2 2024, 27 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were NEA Management Company, LLC ($5.8M), Aisling Capital Management LP ($1.7M) and Vanguard Group Inc. ($1.3M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $11K |
| Exits | 2 | $66K |
All 13F filers, Q1 2024 → Q2 2024: 45,711 shares bought and 18,870 shares sold, net +26,841 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| NEA Management Company, LLC | 0.44% | No change | 1,071,428 | $5.8M |
| Aisling Capital Management LP | 0.74% | No change | 314,286 | $1.7M |
| Vanguard Group Inc. | 0.00% | Add +2.2% | 238,322 | $1.3M |
| Wedbush Securities Inc. | 0.01% | Add +52.8% | 69,500 | $377K |
| Geode Capital Management, LLC | 0.00% | Add +1.8% | 68,242 | $371K |
| Renaissance Technologies | 0.00% | Add +4.3% | 38,850 | $211K |
| Northern Trust Corp. | 0.00% | Reduce -4.1% | 33,381 | $181K |
| State Street Corp. | 0.00% | Add +6.1% | 20,948 | $114K |
| Dimensional Fund Advisors LP | 0.00% | No change | 20,278 | $110K |
| Creative Planning | 0.00% | No change | 17,312 | $94K |
| Matrix Asset Advisors Inc. | 0.01% | No change | 15,000 | $81K |
| BlackRock Inc. | 0.00% | Add +1011.5% | 11,026 | $60K |
| Osaic Holdings, Inc. | 0.00% | Reduce -17.5% | 7,085 | $38K |
| Morgan Stanley | 0.00% | Reduce -15.6% | 3,408 | $19K |
| Bank of America Corp. | 0.00% | Add +2.1% | 2,616 | $14K |
| International Assets Investment Management, LLC | 0.00% | New | 2,000 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +40.1% | 1,867 | $10K |
| Riggs Asset Managment Co. Inc. | 0.00% | No change | 1,400 | $8K |
| US Bancorp \de | 0.00% | No change | 839 | $5K |
| Wells Fargo & Company | 0.00% | Reduce -18.3% | 232 | $1K |
| Group One Trading LLC | 0.00% | No change | 178 | $967 |
| Hilltop National Bank | 0.00% | No change | 73 | $396 |
| JPMorgan Chase & Co. | 0.00% | No change | 38 | $206 |
| Versant Capital Management, Inc | 0.00% | No change | 15 | $81 |
| FMR LLC | 0.00% | No change | 12 | $65 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 9 | $49 |
| Royal Bank of Canada | 0.00% | No change | 15 | $0 |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.